JAZZ News and Press, Jazz Pharmaceuticals plc From 02/26/19

Stock Information

Company Name:	Jazz Pharmaceuticals plc
Stock Symbol:	JAZZ
Market:	NASDAQ
Website:	jazzpharmaceuticals.com

JAZZ JAZZ Quote JAZZ Short JAZZ News JAZZ Articles JAZZ Message Board

Get JAZZ Alerts

News, Short Squeeze, Breakout and More Instantly...

Email Address

JAZZ - Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2018 Financial Results

Total Revenues Increased 17% to $1.9 Billion in 2018 GAAP Diluted EPS of $7.30 ; Adjusted Diluted EPS of $13.70 Launched Vyxeos for AML in the EU and Initiated Broad Development Program Received U.S. Approval of Xyrem for Pediatric Narcolepsy Submitted the MAA to EMA fo...

JAZZ - Notable earnings after Tuesday's close

AAXN , ACAD , AKCA , ARNA , AXGN , BGS , BNFT , CERS , CLGX , CPE , CSGP , CW , DRQ , DVAX , ELF , ENPH , EOG , EVH , FOXF , FRPT , FTR , GWPH , HEI , HPR , HURN , HY , ICFI , IMAX , IMMR , INGN , INN , INSP , JAZZ , JBGS , MASI , MED , MELI , MGRC , M...

JAZZ - Jazz Pharmaceuticals Q4 2018 Earnings Preview

Jazz Pharmaceuticals (NASDAQ: JAZZ ) is scheduled to announce Q4 earnings results on Tuesday, February 26th, after market close. The consensus EPS Estimate is $3.02 (+2.4% Y/Y) and the consensus Revenue Estimate is $459.67M (+5.3% Y/Y). Over the last 2 years, JAZZ has beaten EPS estim...

JAZZ - Jazz Pharmaceuticals to Report 2018 Fourth Quarter and Full Year Financial Results on February 26, 2019

DUBLIN , Feb. 12, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2018 fourth quarter and full year financial results on Tuesday, February 26, 2019 , after the close of the financial markets. Company management will host a l...

JAZZ - Mid Cap Growth Strategy Q4 2018 Commentary